Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Receiver Operating Characteristic Plot01:15

Receiver Operating Characteristic Plot

172
A ROC (Receiver Operating Characteristic) plot is a graphical tool used to assess the performance of a binary classification model by illustrating the trade-off between sensitivity (true positive rate) and specificity (false positive rate). By plotting sensitivity against 1 - specificity across various threshold settings, the ROC curve shows how well the model distinguishes between classes, with a curve closer to the top-left corner indicating a more accurate model. The area under the ROC curve...
172
Sensitivity, Specificity, and Predicted Value01:13

Sensitivity, Specificity, and Predicted Value

337
In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
337
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

484
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
484
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

13.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
13.4K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Alzheimer's disease diagnosis support for brain perfusion SPECT scans in a real-world clinical cohort.

Journal of Alzheimer's disease : JAD·2026
Same author

Lecanemab appropriate use recommendations for clinical practice in the UK.

Journal of neurology, neurosurgery, and psychiatry·2025
Same author

Telehealth-delivered cognitive rehabilitation for people with cognitive impairment as part of the post-COVID syndrome: protocol for a randomised controlled trial as part of the CICERO (Cognitive Impairment in Long COVID: Phenotyping and Rehabilitation) study.

Trials·2024
Same author

Artificial intelligence for diagnostic and prognostic neuroimaging in dementia: A systematic review.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2023
Same author

Examining the effect of interventions in emergency care for older people using a system dynamics decision support tool.

Age and ageing·2023
Same author

A Comprehensive Literature Search of Digital Health Technology Use in Neurological Conditions: Review of Digital Tools to Promote Self-management and Support.

Journal of medical Internet research·2022

相关实验视频

Updated: Jul 2, 2025

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
07:26

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

11.8K

与基线诊断和进展表型相比,ADCOMS的敏感性.

Dave Evenden1, Angus Prosser1, Sofia Michopoulou1,2

  • 1Clinical and Experimental Sciences University of Southampton Southampton UK.

Alzheimer's & dementia (Amsterdam, Netherlands)
|February 26, 2024
PubMed
概括

阿尔茨海默病复合评分 (ADCOMS) 在检测临床试验下降时显示出更高的灵敏度. 集群ADCOMS轨迹揭示了疾病进展的不同模式.

关键词:
接下来我们来看.阿尔茨海默病 阿尔茨海默病聚类集群是指聚类的聚类.纵向变化的纵向变化

更多相关视频

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.7K
Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
04:41

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration

Published on: January 9, 2020

19.0K

相关实验视频

Last Updated: Jul 2, 2025

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
07:26

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

11.8K
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.7K
Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
04:41

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration

Published on: January 9, 2020

19.0K

科学领域:

  • 神经科学是一个神经科学.
  • 临床试验 临床试验
  • 生物统计学 生物统计学

背景情况:

  • 阿尔茨海默病复合评分 (ADCOMS) 是检测痴呆前阶段衰退的敏感指标.
  • 在早期阿尔茨海默病 (AD) 临床试验中,常规措施可能缺乏敏感性.

研究的目的:

  • 使用集群进展特征来比较ADCOMS轨迹.
  • 在患有痴呆前期的人群中识别明显的衰退模式.

主要方法:

  • 使用平均标准偏差比率 (MSDR) 分析基线后的ADCOMS值.
  • 将个人聚集到类似的ADCOMS进展轨迹中.
  • 在不同进展组和基线诊断中对MSDR进行比较.

主要成果:

  • 在临床上重要的进展组中,ADCOMS表现出更高的敏感性.
  • 对于较不严重的基线诊断和边际进展组,ADCOMS的敏感性有限.

结论:

  • 这项研究验证并扩展了ADCOMS.的已知敏感性.
  • 聚类ADCOMS进展为评估大数据集中的疾病轨迹提供了一种新的方法.